NCT05463796
- Conditions
- Adenocarcinoma, Adenomatous Hyperplasia, Adult Cancer Survivors, +79 more
- Locations
-
- Dana Farber Cancer Institute Boston, Massachusetts, United States
Clinical trial condition
Explore clinical trials studying Hematologic Malignancy. Study availability and eligibility vary by location and protocol.
NCT05463796
NCT05887167
NCT06960993
NCT07203534
NCT07257419
NCT06989489
NCT06532773
NCT07006506
NCT07300735